349 related articles for article (PubMed ID: 27913408)
1. Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine.
Kantrowitz JT; Epstein ML; Beggel O; Rohrig S; Lehrfeld JM; Revheim N; Lehrfeld NP; Reep J; Parker E; Silipo G; Ahissar M; Javitt DC
Brain; 2016 Dec; 139(Pt 12):3281-3295. PubMed ID: 27913408
[TBL] [Abstract][Full Text] [Related]
2. Auditory System Target Engagement During Plasticity-Based Interventions in Schizophrenia: A Focus on Modulation of N-Methyl-D-Aspartate-Type Glutamate Receptor Function.
Kantrowitz JT; Swerdlow NR; Dunn W; Vinogradov S
Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Jul; 3(7):581-590. PubMed ID: 29656951
[TBL] [Abstract][Full Text] [Related]
3. Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms.
Kantrowitz JT; Epstein ML; Lee M; Lehrfeld N; Nolan KA; Shope C; Petkova E; Silipo G; Javitt DC
Schizophr Res; 2018 Jan; 191():70-79. PubMed ID: 28318835
[TBL] [Abstract][Full Text] [Related]
4. Dose-Dependent Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia: A Double-Blind, Placebo-Controlled, Randomized, Target Engagement Clinical Trial of the NMDA Glutamate Receptor Agonist d-serine.
Sehatpour P; Iosifescu DV; De Baun HM; Shope C; Mayer MR; Gangwisch J; Dias E; Sobeih T; Choo TH; Wall MM; Medalia A; Saperstein AM; Kegeles LS; Girgis RR; Carlson M; Kantrowitz JT
Biol Psychiatry; 2023 Jul; 94(2):164-173. PubMed ID: 36958998
[TBL] [Abstract][Full Text] [Related]
5. Rodent Mismatch Negativity/theta Neuro-Oscillatory Response as a Translational Neurophysiological Biomarker for N-Methyl-D-Aspartate Receptor-Based New Treatment Development in Schizophrenia.
Lee M; Balla A; Sershen H; Sehatpour P; Lakatos P; Javitt DC
Neuropsychopharmacology; 2018 Feb; 43(3):571-582. PubMed ID: 28816240
[TBL] [Abstract][Full Text] [Related]
6. Intracortical mechanisms of mismatch negativity dysfunction in schizophrenia.
Javitt DC
Audiol Neurootol; 2000; 5(3-4):207-15. PubMed ID: 10859415
[TBL] [Abstract][Full Text] [Related]
7. N-methyl-d-aspartate-type glutamate receptor modulators and related medications for the enhancement of auditory system plasticity in schizophrenia.
Kantrowitz JT
Schizophr Res; 2019 May; 207():70-79. PubMed ID: 29459050
[TBL] [Abstract][Full Text] [Related]
8. Effects of Augmenting N-Methyl-D-Aspartate Receptor Signaling on Working Memory and Experience-Dependent Plasticity in Schizophrenia: An Exploratory Study Using Acute d-cycloserine.
Forsyth JK; Bachman P; Mathalon DH; Roach BJ; Ye E; Asarnow RF
Schizophr Bull; 2017 Sep; 43(5):1123-1133. PubMed ID: 28338977
[TBL] [Abstract][Full Text] [Related]
9. Neural Substrates of Auditory Emotion Recognition Deficits in Schizophrenia.
Kantrowitz JT; Hoptman MJ; Leitman DI; Moreno-Ortega M; Lehrfeld JM; Dias E; Sehatpour P; Laukka P; Silipo G; Javitt DC
J Neurosci; 2015 Nov; 35(44):14909-21. PubMed ID: 26538659
[TBL] [Abstract][Full Text] [Related]
10. Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia.
Javitt DC; Lee M; Kantrowitz JT; Martinez A
Schizophr Res; 2018 Jan; 191():51-60. PubMed ID: 28666633
[TBL] [Abstract][Full Text] [Related]
11. Behavioral and cognitive effects of the N-methyl-D-aspartate receptor co-agonist D-serine in healthy humans: initial findings.
Levin R; Dor-Abarbanel AE; Edelman S; Durrant AR; Hashimoto K; Javitt DC; Heresco-Levy U
J Psychiatr Res; 2015 Feb; 61():188-95. PubMed ID: 25554623
[TBL] [Abstract][Full Text] [Related]
12. Neurophysiological Effects of Bitopertin in Schizophrenia.
Kantrowitz JT; Nolan KA; Epstein ML; Lehrfeld N; Shope C; Petkova E; Javitt DC
J Clin Psychopharmacol; 2017 Aug; 37(4):447-451. PubMed ID: 28590364
[TBL] [Abstract][Full Text] [Related]
13. Neural mechanisms of mismatch negativity dysfunction in schizophrenia.
Lee M; Sehatpour P; Hoptman MJ; Lakatos P; Dias EC; Kantrowitz JT; Martinez AM; Javitt DC
Mol Psychiatry; 2017 Nov; 22(11):1585-1593. PubMed ID: 28167837
[TBL] [Abstract][Full Text] [Related]
14. Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia.
Javitt DC; Zukin SR; Heresco-Levy U; Umbricht D
Schizophr Bull; 2012 Sep; 38(5):958-66. PubMed ID: 22987851
[TBL] [Abstract][Full Text] [Related]
15. The effects of glycine on auditory mismatch negativity in schizophrenia.
Greenwood LM; Leung S; Michie PT; Green A; Nathan PJ; Fitzgerald P; Johnston P; Solowij N; Kulkarni J; Croft RJ
Schizophr Res; 2018 Jan; 191():61-69. PubMed ID: 28602646
[TBL] [Abstract][Full Text] [Related]
16. Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.
Hamilton HK; D'Souza DC; Ford JM; Roach BJ; Kort NS; Ahn KH; Bhakta S; Ranganathan M; Mathalon DH
Schizophr Res; 2018 Jan; 191():87-94. PubMed ID: 28711472
[TBL] [Abstract][Full Text] [Related]
17. Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia.
Umbricht D; Vollenweider FX; Schmid L; Grübel C; Skrabo A; Huber T; Koller R
Neuropsychopharmacology; 2003 Jan; 28(1):170-81. PubMed ID: 12496954
[TBL] [Abstract][Full Text] [Related]
18. Early auditory sensory processing deficits in mouse mutants with reduced NMDA receptor function.
Bickel S; Lipp HP; Umbricht D
Neuropsychopharmacology; 2008 Jun; 33(7):1680-9. PubMed ID: 17712349
[TBL] [Abstract][Full Text] [Related]
19. Grant Report on d-Serine Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia
de la Garrigue N; Glasser J; Sehatpour P; Iosifescu DV; Dias E; Carlson M; Shope C; Sobeih T; Choo TH; Wall MM; Kegeles LS; Gangwisch J; Mayer M; Brazis S; De Baun HM; Wolfer S; Bermudez D; Arnold M; Rette D; Meftah AM; Conant M; Lieberman JA; Kantrowitz JT
J Psychiatr Brain Sci; 2020; 5(4):. PubMed ID: 32856005
[TBL] [Abstract][Full Text] [Related]
20. Sensory deficits and distributed hierarchical dysfunction in schizophrenia.
Leitman DI; Sehatpour P; Higgins BA; Foxe JJ; Silipo G; Javitt DC
Am J Psychiatry; 2010 Jul; 167(7):818-27. PubMed ID: 20478875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
